ARK Genomic Revolution ETF (ARKG)
|Ex-Dividend Date||Dec 29, 2020|
|Day's Range||76.64 - 78.65|
|Inception Date||Oct 31, 2014|
The investment seeks long-term growth of capital. The fund is an actively-managed exchange-traded fund (ETF) that will invest under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors, including healthcare, information technology, materials, energy and consumer discretionary, that are relevant to the fund's investment theme of the genomics revolution (Genomics Revolution Companies). It is non-diversified.
Top 10 Holdings41.89% of assets
|Pacific Biosciences of California||PACB||4.61%|
|Dec 29, 2020||$0.42557||Dec 31, 2020|
|Dec 27, 2019||$1.05395||Dec 31, 2019|
|Dec 27, 2018||$0.26999||Dec 31, 2018|
|Dec 27, 2017||$0.19272||Dec 29, 2017|
|Dec 28, 2016||$0.00||Jan 4, 2017|
|Dec 24, 2015||$0.00||Dec 31, 2015|
Genomics is one of the cornerstones of disruptive growth in the healthcare sector. Relevant to investors is that genomics is still in its nascent stages, indicating that there's a potentially lengthy ru...
Genomics is one of the epicenters of futuristic healthcare investing, and the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) is one of the top exchange traded funds for accessing that theme. Addi...
As experienced investors know, it takes some patience to engage with genomics stocks. That's just the lay of the land with one of the more volatile, yet promising, growth-rich corners of the healthcare ...
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 150,000 shares of Pfizer Inc.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 1.3 million shares of Sema4 Holdings Corp.
A couple ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 7 million shares of Soaring Eagle Acquisition Corp.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought nearly 2 million shares of Soaring Eagle Acquisition Corp.
One ARK Invest exchange-traded fund run by ETF star Cathie Wood bought over 4.1 million shares of Soaring Eagle Acquisition Corp.
One of the primary objectives of genomics is to make strides in areas where traditional healthcare procedures and techniques have failed or aren't generating enough in the way of advancements and improv...
A couple of ARK Invest exchange-traded funds run by ETF star Cathie Wood bought over 850,000 shares of Pacific Biosciences of California Inc.
As an actively managed exchange traded fund, the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) can more nimbly move into new healthcare frontiers than rival index-based products. Synthetic biolo...
Morgan Stanley warns investors 15% correction coming as market overvalued like dot-com days.
With mergers and acquisitions activity yet to heat up, healthcare stocks are lagging the broader market to this point in 2021. The ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG) hasn't been immun...
It's often said that disruptive technologies frequently intersect with each other. For example, cloud computing and the Internet of Things (IoT) are frequently linked to advancements in cybersecurity.
Cathie Wood's genomics ETF is making big bets on the "Genomic Age."